Lutfun Hossain is a Research Fellow at CHERE. She is a health services researcher and aims to further develop her academic career in health economics, applied microeconometrics and health policy research.
Lutfun started her career as a pharmacist working in both a community and hospital setting. She completed a Master of Pharmacy (Research) at the University of Technology Sydney where she explored factors that influence the implementation of health services in a community pharmacy setting. During this time, she was involved in teaching students, was a recipient of the UTS Chancellor’s Research Scholarship, published scientific publications in peer-reviewed journals and presented abstracts at several international conferences. During her research Lutfun also collaborated with experts at the Institute for Sustainable Futures, the Western Sydney Primary Health Network and the University of Lisbon.
Prior to CHERE, Lutfun worked as a clinical product specialist at NPS MedicineWise where she collaborated with internal and external stakeholders (e.g., clinical experts, the Department of Human Services and scientific organisations) to contribute to the development of national programs to improve the quality use of medicines and medical tests. She designed audit and feedback products for GPs and Pharmacists and has extensive experience in working with PBS, MBS and MedicineInsight data.
Hossain, LN, Tudball, J, Franco-Trigo, L, Durks, D, Benrimoj, SI & Sabater-Hernández, D 2018, 'A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level.', Research in social & administrative pharmacy : RSAP, vol. 14, pp. 765-775.View/Download from: UTS OPUS or Publisher's site
A key early step to enhance the integration of community pharmacy services (CPSs) into primary care practice is identifying key determinants of practice (i.e., critical circumstances that influence the implementation of such services). Involving relevant stakeholders in identifying key determinants enables findings to be more relevant to the context in which CPSs will be implemented.To identify key determinants of practice that can influence the implementation of government-funded CPSs in a primary health network in Australia.A stakeholder collaborative approach was used, encompassing two phases. In the first phase, semi-structured interviews were conducted with ground-level stakeholders in Western Sydney between August 2016 to October 2016. Framework analysis was used to code and analyse the data from the interviews into determinants of pharmacy practice. In the second phase, a workshop was conducted with a mixed-group of ground-level and system-level stakeholders from the primary health network to identify key determinants. A four-quadrant prioritization matrix was employed in the workshop to classify determinants based on their importance and feasibility.Sixty-five determinants of practice that can influence CPS implementation were identified in Phase 1. These determinants were allocated at different levels of the healthcare system, and can exist as a barrier or facilitator or both. Twenty-two key determinants were selected in Phase 2, of which three were agreed to be addressed initially: (1) Patient understanding of the aims of the service; (2) Commitment of the organization and its leaders to provide services; (3) Coordination of the healthcare system to prompt collaboration between pharmacists and GPs.This collaborative stakeholder approach identified a set of key determinants of pharmacy practice in this Australian primary care setting. To enhance the implementation of CPSs in this region, initial efforts should be aimed at developing implementation strate...
Sabater-Hernandez, D, Tudball, J, Ferguson, C, Franco-Trigo, L, Hossain, LN & Benrimoj, SI 2018, 'A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation', BMC HEALTH SERVICES RESEARCH, vol. 18.View/Download from: UTS OPUS or Publisher's site
Durks, D, Fernandez-Llimos, F, Hossain, LN, Franco-Trigo, L, Benrimoj, SI & Sabater-Hernández, D 2017, 'Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review.', Health Education and Behavior, vol. 44, no. 4, pp. 524-535.View/Download from: UTS OPUS or Publisher's site
Intervention Mapping is a planning protocol for developing behavior change interventions, the first three steps of which are intended to establish the foundations and rationales of such interventions.This systematic review aimed to identify programs that used Intervention Mapping to plan changes in health care professional practice. Specifically, it provides an analysis of the information provided by the programs in the first three steps of the protocol to determine their foundations and rationales of change.A literature search was undertaken in PubMed, Scopus, SciELO, and DOAJ using "Intervention Mapping" as keyword. Key information was gathered, including theories used, determinants of practice, research methodologies, theory-based methods, and practical applications.Seventeen programs aimed at changing a range of health care practices were included. The social cognitive theory and the theory of planned behavior were the most frequently used frameworks in driving change within health care practices. Programs used a large variety of research methodologies to identify determinants of practice. Specific theory-based methods (e.g., modelling and active learning) and practical applications (e.g., health care professional training and facilitation) were reported to inform the development of practice change interventions and programs.In practice, Intervention Mapping delineates a three-step systematic, theory- and evidence-driven process for establishing the theoretical foundations and rationales underpinning change in health care professional practice.The use of Intervention Mapping can provide health care planners with useful guidelines for the theoretical development of practice change interventions and programs.
Hossain, LN, Fernandez-Llimos, F, Luckett, TR, Moullin, JC, Durks, D, Franco Trigo, L, Benrimoj, S & Sabater Hernandez, D 2017, 'Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners', BMJ Open, vol. 7, no. 9, pp. 1-14.View/Download from: UTS OPUS or Publisher's site
Objectives The integration of community pharmacy services (CPSs) into primary care practice can be enhanced by assessing (and further addressing) the elements that enable (ie, facilitators) or hinder (ie, barriers) the implementation of such CPSs. These elements have been widely researched from the perspective of pharmacists but not from the perspectives of other stakeholders who can interact with and influence the implementation of CPSs. The aim of this study was to synthesise the literature on patients', general practitioners' (GPs) and nurses' perspectives of CPSs to identify barriers and facilitators to their implementation in Australia.
Methods A meta-synthesis of qualitative studies was performed. A systematic search in PubMed, Scopus and Informit was conducted to identify studies that explored patients', GPs' or nurses' views about CPSs in Australia. Thematic synthesis was performed to identify elements influencing CPS implementation, which were further classified using an ecological approach.
Results Twenty-nine articles were included in the review, addressing 63 elements influencing CPS implementation. Elements were identified as a barrier, facilitator or both and were related to four ecological levels: individual patient (n=14), interpersonal (n=24), organisational (n=16) and community and healthcare system (n=9). It was found that patients, nurses and GPs identified elements reported in previous pharmacist-informed studies, such as pharmacist's training/education or financial remuneration, but also new elements, such as patients' capability to follow service's procedures, the relationships between GP and pharmacy professional bodies or the availability of multidisciplinary training/education.
Conclusions Patients, GPs and nurses can describe a large number of elements influencing CPS implementation. These elements can be combined with previous findings in pharmacists-informed studies to produce a comprehensive framework to assess barriers a...
Franco-Trigo, L, Hossain, LN, Durks, D, Fam, D, Inglis, SC, Benrimoj, SI & Sabater-Hernández, D 2017, 'Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease', Research in Social and Administrative Pharmacy, vol. 13, no. 3, pp. 539-552.View/Download from: UTS OPUS or Publisher's site
Participatory approaches involving stakeholders across the health care system can help enhance the development, implementation and evaluation of health services. These approaches may be particularly useful in planning community pharmacy services and so overcome challenges in their implementation into practice. Conducting a stakeholder analysis is a key first step since it allows relevant stakeholders to be identified, as well as providing planners a better understanding of the complexity of the health care system.The main aim of this study was to conduct a stakeholder analysis to identify those individuals and organizations that could be part of a leading planning group for the development of a community pharmacy service (CPS) to prevent cardiovascular disease (CVD) in Australia.An experienced facilitator conducted a workshop with 8 key informants of the Australian health care system. Two structured activities were undertaken. The first explored current needs and gaps in cardiovascular care and the role of community pharmacists. The second was a stakeholder analysis, using both ex-ante and ad-hoc approaches. Identified stakeholders were then classified into three groups according to their relative influence on the development of the pharmacy service. The information gathered was analyzed using qualitative content analysis.The key informants identified 46 stakeholders, including (1) patient/consumers and their representative organizations, (2) health care providers and their professional organizations and (3) institutions and organizations that do not directly interact with patients but organize and manage the health care system, develop and implement health policies, pay for health care, influence funding for health service research or promote new health initiatives. From the 46 stakeholders, a core group of 12 stakeholders was defined. These were considered crucial to the service's development because they held positions that could drive or inhibit progress. Sec...
Sabater-Hernandez, D, Moullin, JC, Hossain, LN, Durks, D, Franco-Trigo, L, Fernandez-Llimos, F, Martinez-Martinez, F, Saez-Benito, L, de la Sierra, A & Benrimoj, SI 2016, 'Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach', AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, vol. 73, no. 3, pp. 156-164.View/Download from: UTS OPUS or Publisher's site
Sabater-Hernández, D, Sabater-Galindo, M, Fernandez-Llimos, F, Rotta, I, Hossain, LN, Durks, D, Franco-Trigo, L, Lopes, LA, Correr, CJ & Benrimoj, SI 2016, 'A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease.', Journal of managed care & specialty pharmacy, vol. 22, no. 6, pp. 699-713.View/Download from: UTS OPUS or Publisher's site
Cardiovascular disease (CVD) is the leading cause of death worldwide and has a substantial impact on people's health and quality of life. CVD also causes an increased use of health care resources and services, representing a significant proportion of health care expenditure. Integrating evidence-based community pharmacy services is seen as an asset to reduce the burden of CVD on individuals and the health care system.To (a) identify community pharmacy evidence-based services designed to help prevent CVD and (b) provide fundamental information that is needed to assess their potential adaptation to other community pharmacy settings.This review used the DEPICT database, which includes 488 randomized controlled trials (RCT) that address the evaluation of pharmacy services. Articles reviewing these RCTs were identified for the DEPICT database through a systematic search of the following databases: MEDLINE, Scopus, SciELO (Scientific Electronic Library Online), and DOAJ (Directory of Open Access Journals). The DEPICT database was reviewed to identify evidence-based services delivered in the community pharmacy setting with the purpose of preventing CVD. An evidence-based service was defined as a service that has been shown to have a positive effect (compared with usual care) in a high-quality RCT. From each evidence-based service, fundamental information was retrieved to facilitate adaptation to other community pharmacy settings.From the DEPICT database, 14 evidence-based community pharmacy services that addressed the prevention of CVD were identified. All services, except 1, targeted populations with a mean age above 60 years. Pharmacy services encompassed a wide range of practical applications or techniques that can be classified into 3 groups: activities directed at patients, activities directed at health care professionals, and assessments to gather patient-related information in order to support the previous activities.This review provides pharmacy service planners...
Franco-Trigo, L, Durks, D, Lutfun, NH, Fam, D, Benrimoj, S & Sabater-Hernández, D 2015, 'Identifying a planning group for the development, implementation and evaluation of a pharmacy service aimed at preventing cardiovascular diseases in Australia', 75th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Dusseldorf, Germany.
Intervention Mapping (IM) provides a comprehensive framework that can help pharmacy service
planners overcome current challenges in pharmacy practice, such as the development, implementation
and evaluation of pharmacy services. According to IM, pharmacy service planning must begin by
establishing a stakeholder planning group.A group of 6-7 key informants will identify potential
opportunities and gaps related to community pharmacy and cardiovascular health, and map a
‘preliminary list’ of stakeholders. A snowballing exercise will be conducted with the
identified stakeholders to obtain a comprehensive ‘final list’. Lastly, mapping exercises
will be performed to assess the relevance, interests and attitudes of the different stakeholders. This
information will be used to identify key stakeholders to be included in the planning group.At the
moment, the key informants have been identified, contacted and invited to attend the first workshop
that has been structured in four parts. Qualitative methodologies (i.e., focus group/brainstorming) and
social network analysis technique have been selected to identify the opportunities and gaps and obtain
the preliminary list of stakeholders.The results of this study will provide a list of key stakeholders who
can be part of the planning group for the development, implementation and evaluation of a pharmacy
service in Australia.